US-based Blue Water Vaccines has an option on University of Oxford research into a universal influenza shot and is looking to raise $15m in funding.

Blue Water Vaccines, a US-based influenza shot developer based on University of Oxford research, is seeking $15m in funding from undisclosed investors.
Blue Water has entered an option agreement with Oxford to advance the concept of a universal influenza jab pioneered in the Department of Zoology.
The vaccine will function by hitting viral modules whose attributes vary less than the epitopes targeted by conventional flu injections, as such prompting a comprehensive immune response against all strains and potentially…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?